Company Search:
Advanced Search
Sponsored Links
Open Orphan PLC Company Snapshot
Open Orphan PLC operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Open Orphan PLC with three other companies in this sector in UNITED KINGDOM : Fusion Antibodies PLC (2019 sales of £2.18 million [US$3.00 million] ), Redx Pharma PLC (£3.13 million [US$4.30 million] of which 100% was pharmaceutical), and Avacta Group Plc (£3.89 million [US$5.34 million] of which 60% was Life Sciences).

Sales Analysis. Sales fell dramatically in 2019: During the year ended December of 2019, sales at Open Orphan PLC were £3.84 million (US$5.28 million). This is a sharp decrease of 68.8% versus 2018, when the company's sales were £12.33 million. The sales level in 2019 was fairly close to the level five years ago: in 2014, Open Orphan PLC had sales of £3.92 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Open Orphan PLC
  Stock Performance Chart for Open Orphan PLC
  Stock Data: Recent Stock Performance:
  Current Price (4/1/2021): 33.50p
(Figures in Pounds Sterling)
1 Week -2.9%   13 Weeks 17.5%  
4 Weeks 29.8%   52 Weeks 467.8%  
Open Orphan PLC Key Data:
  Ticker: ORPH Country: United Kingdom
  Exchanges: LON Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 3,844,000
(Year Ending Jan 2020).
Employees: 132
  Currency: Pounds Sterling Market Cap: 222,393,133
  Fiscal Yr Ends: December Shares Outstanding: 663,860,098
  Share Type: Ordinary Closely Held Shares: 142,955,550
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.